Stenting and abciximab in primary angioplasty: A review of current status

Italian Heart Journal

Volumn 6, Issue 11, 2005, Pages 874-880

  De Luca, Giuseppe ^a,b   Suryapranata, Harry ^a   Piscione, Federico ^b   Barbato, Emanuele ^c   Chiariello, Massimo ^b  

^a ISALA HOSPITAL   (Netherlands)

^b CARDIOVASCULAR CENTER   (Belgium)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Abciximab; Angioplasty, primary; Myocardial infarction; ST segment elevation; Stenting

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; BIOMATERIAL; FIBRINOGEN RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

DRUG ANTAGONISM; ELECTROCARDIOGRAPHY; HEART INFARCTION; HUMAN; INSTRUMENTATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; COATED MATERIALS, BIOCOMPATIBLE; ELECTROCARDIOGRAPHY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PRACTICE GUIDELINES; STENTS;

EID: 33644802014     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. George BS, Voorhees WD, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 1993; 22: 135-43.
2. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-88.
3. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-9.
4. Brener SJ, Barr LA, Burchenal JEB, et al, on behalf of the ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998; 98: 734-41.
5. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998; 352: 87-92.
6. Suryapranata H, van't Hof A, Hoorntje JC, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502-5.
7. Suryapranata H, Ottervanger JP, Nibbering E, et al. Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction. Heart 2001; 85: 667-71.
8. Antoniucci D, Santoro GM, Bolognese L, et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusion (FRESCO) trial. J Am Coll Cardiol 1998; 31: 1234-9.
9. Rodriguez A, Bernardi V, Fernández M, et al. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am J Cardiol 1998; 81: 1286-91.
10. Saito S, Hosokawa G, Tanaka S, et al. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: final results of the Primary Angioplasty Versus Stent Implantation in Acute Myocardial Infarction (PASTA) trial. PASTA Trial Investigators. Catheter Cardiovasc Interv 1999; 48: 262-8.
11. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341: 1949-56.
12. Scheller B, Hennen N, Severin-Kneib S, et al. Follow-up of the PSAAMI study population (Primary Stenting vs Angioplasty in Acute Myocardial Infarction). (abstr) J Am Coll Cardiol 1999; 33 (Suppl A): 29A.
13. Kawashima A, Ueda K, Nishida I, et al. Quantitative angiographic analysis of restenosis of primary stenting using Wiktor stent for acute myocardial infarction: results from a multicenter randomized PRISAM study. (abstr) Circulation 1999; 100 (Suppl I): I-856.
14. Millard L, Hamon M, Khalife K, et al. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators. J Am Coll Cardiol 2000; 35: 1729-36.
15. Schwimmbeck PL, Spencker S, Hohmann C, et al. Results from the Berlin Stent Study in Acute Myocardial Infarction. (abstr) Circulation 2000; 102 (Suppl II): II-813.
16. Stone G, Grined CL, Cox AD, et al, for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346: 957-66.
17. Stone GW, Brodie BR, Griffin JJ, et al. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction (PAMI) Stent Pilot Trial. Circulation 1999; 99: 1548-54.
18. Zhu MM, Feit A, Chadow H, Alam M, Kwam T, Clark LT. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. Am J Cardiol 2001; 88: 297-301.
19. Tiefenbrunn AJ, Chandra NC, French WJ, et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1998; 31: 1240-5.
20. GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621-8.
21. Ruygrok PN, Melkert R, Morel MA, et al. Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators. J Am Coll Cardiol 1999; 34: 1507-11.
22. Suryapranata H, De Luca G, Zijlstra F, et al. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomized comparison in a large unselected cohort of patients. Heart 2005; 91: 641-5.
23. Kastrati A, Mehilli J, Nekolla S, et al. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol 2004; 43: 734-41.
24. Burzotta F, Trani C, Prati F, et al. Comparison of outcomes (early and six-month) of direct stenting with conventional stenting (a meta-analysis of ten randomized trials). Am J Cardiol 2003; 91: 790-6.
25. Capozzolo C, Piscione F, De Luca G, et al. Direct coronary stenting: effects on coronary blood flow, immediate and late clinical results. Catheter Cardiovasc Interv 2001; 53: 464-73.
26. Rogers C, Parikh S, Seifert P, Edelman ER. Endogenous cell seeding: remnant endothelium after stenting enhances vascular repair. Circulation 1996; 94: 2909-14.
27. Henriques JP, Zijlstra F, Ottervanger JP, et al Incidence and clinical significance of distal embolisation during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23: 1112-7.
28. Loubeyre C, Morice MC, Lefevre T, et al. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol 2002; 39: 15-21.
29. Gasior M, Gierlokta A, Lekston K, et al. Randomized comparison of direct stenting and stenting after predilatation in acute myocardial infarction. In-hospital results of DIRAMI trial. (abstr) Eur Heart J 2000; 175.
30. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
31. Stone GW, Ellis SG, Cox DA, et al, for the TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-31.
32. Lemos PA, Saia F, Hofma SH, et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004; 43: 704-8.
33. Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998; 98: 2695-701.
34. Neumann FJ, Kastrati A, Schmitt C, et al. Effect of glycoprotein IIb/ IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol 2000; 35: 915-21.
35. Montalescot G, Barragan P, Wittenberg O, et al, for the ADMIRAL Investigators. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-903.
36. Petronio AS, Musumeci G, Limbruno U, et al. Abciximab improves 6-month clinical outcome after rescue coronary angioplasty. Am Heart J 2002; 143: 334-41.
37. Antoniucci D, Migliorini A, Parodi G, et al. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone. Circulation 2004; 109: 1704-6.
38. Zorman S, Zorman D, Noc M. Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty. Am J Cardiol 2002; 90: 533-6.
39. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413-9.
40. Chan AW, Chew DP, Bhatt DL, et al. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2002; 89: 132-6.
41. Antoniucci D, Valenti R, Migliorini A, et al. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 2002; 90: 353-7.
42. De Luca G, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005; 293: 1759-65.
43. Henriques JP, Zijlstra F, Ottervanger JP, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23: 1112-7.
44. Marso SP, Lincoff AM, Ellis SG, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy. Circulation 1999; 100: 2477-84.
45. Montalescot G, Borentain M, Payot L, Collet JP, Thomas D. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. JAMA 2004; 292: 362-6.
46. Arntz HR, Schroder JF, Pels K, et al. Prehospital versus periprocedural administration of abciximab in STEMI: early vs late results from the randomised REOMOBILE-study. (abstr) Eur Heart J 2003; 24 (Suppl): 268.
47. Mesquita Gabriel H, Oliveira J, Canas da Silva P, et al. Early administration of abciximab in the emergency room improves microperfusion after primary percutaneous coronary intervention, as assessed by the TIMI frame count: results of the ERAMI trial. (abstr) Eur Heart J 2003; 24 (Suppl): 543.
48. Cutlip DE, Ricciardi MJ, Ling FS, et al. Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction. Am J Cardiol 2003; 92: 977-80.
49. Lee DP, Herity NA, Hiatt BL, et al. Adjunctive platelet glycoprotein IIb/ IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the Tirofiban Given in the Emergency Room Before Primary Angioplasty (TIGER-PA) pilot trial. Circulation 2003; 107: 1497-501.
50. van't Hof AW, Ernst N, de Boer MJ, et al. Facilitation of primary coronary angioplasty by early start of a glycoprotein IIb/IIIa inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. Eur Heart J 2004; 25: 837-46.
51. Batchelor WB, Tolleson TR, Huang Y, et al. Randomized comparison of platelet inhibition with abciximab, tirofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison of Measurements of Platelet Aggregation with Aggrastat, Reopro, and Eptifibatide. Circulation 2002; 106: 1470-6.
52. Gawaz M, Ruf A, Pogatsa-Murray G, et al. Incomplete inhibition of platelet aggregation and glycoprotein IIb/IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb/IIIa receptors. Thromb Haemost 2000; 83: 915-22.
53. Wohrle J, Grebe OC, Nusser T, et al. Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty. Circulation 2003; 107: 1840-3.
54. Bellandi F, Maioli M, Gallopin M, Toso A, Dabizzi RP. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Catheter Cardiovasc Interv 2004; 62: 186-92.
55. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003; 108: 1809-14.
56. Li RH, Herrmann HC. Facilitated percutaneous coronary intervention: a novel concept in expediting and improving acute myocardial infarction care. Am Heart J 2000; 140 (Suppl): S125-S135.
57. De Luca G, Suryapranata H, Ottervanger JP, et al. Time-delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute delay counts. Circulation 2004; 109; 1223-5.
58. De Luca G, Suryapranata H, Zijlstra F, et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003; 423: 991-7.
59. De Luca G, Ernst N, Zijlstra F, et al. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2004; 43: 1363-7.